Experts have warned Beijing to speed up the approval process for updated vaccines to combat new coronavirus variants as the disease sweeps across China after authorities eased heavy-handed pandemic controls.
The majority of the Chinese population has been vaccinated with the inactivated Sinovac and Sinopharm jabs, which were designed to target the original virus strain identified in Wuhan in 2020.
“We can’t rely on old vaccines which are currently being used nationwide going forward,” said a Beijing-based adviser to the Chinese Center for Disease Control and Prevention.
您已阅读13%（574字），剩余87%（3846字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。